Legalising lower dosage cannabis products could 'ignite industry'

Legalising lower dosage cannabis products could 'ignite industry'
Mitch Cuevas, pharmaceutical director at Katikati based medicinal cannabis firm Eqalis, said NZ is 'missing out' on an obvious export opportunity. (Image: Eqalis)
Brent Melville
Easing restrictions on low-level cannabidiol (CBD) for over-the-counter sales could boost cannabis earnings fourfold, creating a $2 billion sector within the next eight years, a new report says.Dr Nick Marsh, an analyst and consultant with Next Corp, said regulatory reform allowing expanded use of low potency CBD for nutraceuticals and food products could ignite the industry’s earning power.In New Zealand, any strength CBD is scheduled as a restricted medicine under the Medicines Act and therefore must be prescribed by a medical professio...

More Health

Health NZ weighs AI tools as doctors see productivity gains
Health

Health NZ weighs AI tools as doctors see productivity gains

Health NZ is yet to endorse any AI tools for staff use.

Radius buys care home off Arvida
Property

Radius buys care home off Arvida

Radius Care will have another 109 beds in Christchurch.

Gregor Thompson 30 Apr 2025
Why this tech firm sees a Trump tariff opportunity
Markets The small cap wrap

Why this tech firm sees a Trump tariff opportunity

Plus IkeGPS' wins in the US, Trade Window targets trade war, TruScreen, and more.

The $20b plan to improve our old, risk-prone hospitals
Infrastructure

The $20b plan to improve our old, risk-prone hospitals

Simeon Brown released the long-awaited plan and details of a new Dunedin Hospital tender.

Oliver Lewis 16 Apr 2025